Jarrett Revels

Executive Officer at Beacon Biosignals.

Raised on Beacon Biosignals filings

$103.3M

of $103.3M offered across 1 Form D filing

Form D filings: 1
Teammates: 4
Last filing: Apr 15, 2026

Company

Beacon Biosignals

Healthcare · Boston, MA

EEG analytics and home sleep tests for drug trials

EEG analytics and home sleep tests for drug trials

Investors: 43

Investors: 43
Sector: Healthcare
HQ: Boston, MA

Beacon Biosignals filings

Beacon Biosignals Form D filings
Filed	Security	Sold of offered	Filing
Apr 15, 2026	Equity	$103.3M/ $103.3M	Form D

EquityFiled Apr 15, 2026Form D
$103.3M/ $103.3M

Works with

Also named on Beacon Biosignals filings

Jacob A. Donoghue, M.D., Ph.D.Chief Executive Officer, Form D signerForm D signer Naveen RaoDirector Caitlin DonovanDirector Pavel RaifeldDirector